Abstract

Treatment of Patients Age 70 and over with Inpatient High-Dose Continuous Infusion Interleukin-2 for Metastatic Melanoma and Kidney Cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Correlation Between Development of Pulmonary Edema and Response of Pulmonary Metastases of Metastatic Melanoma and Kidney Cancer to High-Dose Continuous-Infusion Interleukin-2
Walter D.Y Quan ... Francine Quan
Cancer Biotherapy & Radiopharmaceuticals | VOL. 20
Walter D.Y Quan, et. al.Walter D.Y Quan ... Francine Quan
01 Apr 2005
High-Dose Continuous Infusion Plus Pulse Interleukin-2 and Famotidine in Metastatic Kidney Cancer
Walter Quan ... Chris Taylor
Cancer Biotherapy & Radiopharmaceuticals | VOL. 20
Walter Quan, et. al.Walter Quan ... Chris Taylor
01 Feb 2005
Activity of Continuous Infusion Plus Pulse Interleukin-2 with Famotidine in Patients with Metastatic Kidney Cancer or Melanoma Previously Treated with Interleukin-2
Walter D.Y Quan ... Mikhail Vinogradov
Cancer Biotherapy & Radiopharmaceuticals | VOL. 21
Walter D.Y Quan, et. al.Walter D.Y Quan ... Mikhail Vinogradov
01 Oct 2006
Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response.
Steven A Rosenberg ... James C Yang
ANNALS of SURGERY | VOL. 228
Steven A Rosenberg, et. al.Steven A Rosenberg ... James C Yang
01 Sep 1998
View more papers

More From: Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy

Paper Title
Journal
Date
Author
Corneal Transplant Rejection Following Durvalumab Therapy in a Patient With NSCLC: A Case Report.
Luise Froessl ... Jonathan Dowell
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy | VOL. -
Luise Froessl, et. al.Luise Froessl ... Jonathan Dowell
30 Jul 2024
Blood Tumor Mutational Burden Alone Is Not a Good Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Gastrointestinal Tumors.
James Yu ... Richard Kim
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy | VOL. -
James Yu, et. al.James Yu ... Richard Kim
16 Jul 2024
HES6 Mediates Oxidative Phosphorylation Pathway to Promote Immune Infiltration of CD8+ T Cells in Lung Adenocarcinoma.
Zhoumiao Chen ... Zhao Chen
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy | VOL. -
Zhoumiao Chen, et. al.Zhoumiao Chen ... Zhao Chen
15 Jul 2024
Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy.
David J Einstein ... David F Mcdermott
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy | VOL. -
David J Einstein, et. al.David J Einstein ... David F Mcdermott
15 Jul 2024
View more papers